Back to mobile site

Regeneron Pharma (REGN) PT Raised to $352 at Cowen

November 5, 2019 3:42 PM EST Send to a Friend
Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $352.00 (from $349.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login